Drug intelligence / Profile preview

fenvalerate

Development stage
Unknown
Lead developer
Sumitomo Chemical
Modality
Small Molecules
Administration
Topical, Dermal, Spray (environmental/agricultural), Dusting (agricultural), Ultra-low Volume Spray (environmental/agricultural), Granulated (environmental/agricultural)
01

Overview

**Fenvalerate** is a synthetic pyrethroid insecticide composed of a mixture of four stereoisomers, with the 2-S alpha (SS) configuration (known as esfenvalerate) as the most potent isomer[1][5]. It is primarily used to control insects in agricultural crops (especially cotton), public health applications, and animal husbandry, and is effective against a wide spectrum of insect pests, including those resistant to other classes of insecticides[1][3][5][7]. Fenvalerate functions as a neurotoxic agent, disrupting insect nervous system function by prolonging the opening of voltage-gated sodium channels in nerve cells, leading to paralysis and death[7]. Notably, fenvalerate is moderately toxic to mammals and highly toxic to aquatic life and bees[1]. Its metabolism involves ester cleavage and modification of acid and alcohol moieties, and it is available in several formulations, including emulsifiable concentrates, dusts, granules, and ultra-low volume sprays[1][7]. Fenvalerate was first introduced in 1976 and has been widely used internationally[5].

Brand names
PydrinSumicidinSumipowerBelmarkEctrinTiradeAgrofenAqmatrineEvercide 2362Evercide2362Evercide-2362FenaxinFenkemFenkillFenoxinFenvalFuritrothionInsectralPhenvaleratePhenoxinTributeSanmarton
Other names
Benzeneacetic acid, 4-chloro-α-(1-methylethyl)-, cyano(3-phenoxyphenyl)methyl esterα-Cyano-3-phenoxybenzyl 2-(4-chlorophenyl)isovalerateα-Cyano-3-phenoxybenzyl-2-(4-chlorophenyl)-3-methylbutyrateCyano(3-phenoxyphenyl)methyl 4-chloro-α-(1-methylethyl)benzeneacetate4-Chloro-α-(1-methylethyl)benzeneacetic acid cyano(3-phenoxyphenyl)methyl ester(+)Alpha-cyano-3-phenoxybenzyl-(+)-alpha-(4-chlorophenyl)isovaleratealphaCyano(3phenoxyphenyl)methyl4chloroalpha(1methylethyl)benzeneacetate110-167-2
02

Targets

NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on fenvalerate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fenvalerate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call